Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
Clinical trial NCT00311584 · COMPLETED
Trial details
- NCT number
- NCT00311584
- Sponsor
- Children's Oncology Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2009-03-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.